Anika Therapeutics wins US FDA's approval to market MONOVISC
M2 - Wed Feb 26, 5:53AM CST
US-based tissue therapeutics company Anika Therapeutics (NasdaqGS:ANIK) reported on Tuesday the receipt of marketing approval from the US Food and Drug Administration (FDA) for MONOVISC, for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative, non-pharmacologic therapy and to simple analgesics.
ANIK: 41.30 (-0.17)